![Heparin Dosing in Obese Pediatric Patients in the Cardiac Catheterization Laboratory | Semantic Scholar Heparin Dosing in Obese Pediatric Patients in the Cardiac Catheterization Laboratory | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4dac380860880de416e935925e036721c712a90b/3-Table3-1.png)
Heparin Dosing in Obese Pediatric Patients in the Cardiac Catheterization Laboratory | Semantic Scholar
![Protocol of dosage of heparin. Extracorporeal membrane oxygenation was... | Download Scientific Diagram Protocol of dosage of heparin. Extracorporeal membrane oxygenation was... | Download Scientific Diagram](https://www.researchgate.net/publication/351137928/figure/fig2/AS:1017798998368259@1619673599263/Protocol-of-dosage-of-heparin-Extracorporeal-membrane-oxygenation-was-started-after-the.png)
Protocol of dosage of heparin. Extracorporeal membrane oxygenation was... | Download Scientific Diagram
![Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants | Clinical Drug Investigation Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants | Clinical Drug Investigation](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40261-016-0435-6/MediaObjects/40261_2016_435_Fig1_HTML.gif)
Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants | Clinical Drug Investigation
![Table 2 from Randomized Comparison of a Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation | Semantic Scholar Table 2 from Randomized Comparison of a Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3fc604dbc4eb7711eeacb593d52b5c8a58a25b30/5-Table2-1.png)
Table 2 from Randomized Comparison of a Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation | Semantic Scholar
![Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment | BMC Cardiovascular Disorders | Full Text Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment | BMC Cardiovascular Disorders | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12872-021-02032-3/MediaObjects/12872_2021_2032_Fig1_HTML.png)
Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment | BMC Cardiovascular Disorders | Full Text
![JCM | Free Full-Text | Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures JCM | Free Full-Text | Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures](https://www.mdpi.com/jcm/jcm-10-04240/article_deploy/html/images/jcm-10-04240-g001.png)
JCM | Free Full-Text | Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures
![Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment | BMC Cardiovascular Disorders | Full Text Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment | BMC Cardiovascular Disorders | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12872-021-02032-3/MediaObjects/12872_2021_2032_Fig2_HTML.png)
Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment | BMC Cardiovascular Disorders | Full Text
![Fresh frozen plasma: A solution to heparin resistance during extracorporeal membrane oxygenation (ECMO) - ScienceDirect Fresh frozen plasma: A solution to heparin resistance during extracorporeal membrane oxygenation (ECMO) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2090730318300574-gr1.jpg)
Fresh frozen plasma: A solution to heparin resistance during extracorporeal membrane oxygenation (ECMO) - ScienceDirect
![More Effective Anticoagulation During Non-Cardiac Arterial Procedures Using Activated Clotting Time Guided Heparin Administration - ScienceDirect More Effective Anticoagulation During Non-Cardiac Arterial Procedures Using Activated Clotting Time Guided Heparin Administration - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0890509621003745-gr2.jpg)
More Effective Anticoagulation During Non-Cardiac Arterial Procedures Using Activated Clotting Time Guided Heparin Administration - ScienceDirect
![Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients | Semantic Scholar Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a415365cb89fa10e183d5e98068e44bb13985cad/4-Table1-1.png)
Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients | Semantic Scholar
![Table 2 from A Weight-Based Heparin Protocol for Improved Anticoagulation in a Coronary Care Unit | Semantic Scholar Table 2 from A Weight-Based Heparin Protocol for Improved Anticoagulation in a Coronary Care Unit | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3f850704b88362ad3e3b33aac065e67f2c116d76/2-Table2-1.png)
Table 2 from A Weight-Based Heparin Protocol for Improved Anticoagulation in a Coronary Care Unit | Semantic Scholar
![Table 4 from Randomized Comparison of a Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation | Semantic Scholar Table 4 from Randomized Comparison of a Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3fc604dbc4eb7711eeacb593d52b5c8a58a25b30/6-Table4-1.png)
Table 4 from Randomized Comparison of a Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation | Semantic Scholar
![Traditional and non-traditional anticoagulation management during extracorporeal membrane oxygenation - Koster- Annals of Cardiothoracic Surgery Traditional and non-traditional anticoagulation management during extracorporeal membrane oxygenation - Koster- Annals of Cardiothoracic Surgery](https://cdn.amegroups.cn/journals/acs/files/journals/9/articles/16529/public/16529-PB3-7362-R1.png/w300)